Laboratory analysis
Ended Purchase Order Awarded Last action
- Contract number
- 75N91025P00153
- Awardee
-
Eurofins Pharma Bioanalytics Services US, LLC UEI JL23CDPHLER3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,075
Award facts
- Contract value 100% obligated
- $12,075.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- St Peters, MO 63304, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a $12,075.00 firm fixed price purchase order contract for laboratory analysis services to Eurofins Pharma Bioanalytics Services US, LLC, a for-profit foreign-owned company. The contract has a period of performance through February 7, 2025 and was awarded on January 29, 2025 with no set-aside designation. The award does not appear to be associated with a larger contract vehicle.
Quick answers
Who was awarded contract 75N91025P00153?
75N91025P00153 was awarded to Eurofins Pharma Bioanalytics Services US, LLC by National Cancer Institute (National Institutes of Health) on January 29, 2025.
How much is contract 75N91025P00153 worth?
The government has obligated $12,075 on 75N91025P00153.
Was contract 75N91025P00153 competed?
The extent of competition for 75N91025P00153 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award